EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 320 filers reported holding EDITAS MEDICINE INC in Q3 2021. The put-call ratio across all filers is 2.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,451,021 | +8.2% | 314,234 | +14.2% | 0.00% | – |
| Q2 2023 | $2,264,546 | +18.5% | 275,158 | +4.4% | 0.00% | – |
| Q1 2023 | $1,911,587 | -16.1% | 263,667 | +2.7% | 0.00% | -100.0% |
| Q4 2022 | $2,277,683 | -26.5% | 256,785 | +1.4% | 0.00% | 0.0% |
| Q3 2022 | $3,100,000 | +12.5% | 253,291 | +8.7% | 0.00% | 0.0% |
| Q2 2022 | $2,756,000 | -49.8% | 232,964 | -19.4% | 0.00% | 0.0% |
| Q1 2022 | $5,494,000 | -28.1% | 288,878 | +0.4% | 0.00% | 0.0% |
| Q4 2021 | $7,642,000 | -38.3% | 287,818 | -4.5% | 0.00% | -50.0% |
| Q3 2021 | $12,385,000 | -20.0% | 301,461 | +10.3% | 0.00% | -33.3% |
| Q2 2021 | $15,477,000 | +45.1% | 273,254 | +7.6% | 0.00% | +50.0% |
| Q1 2021 | $10,670,000 | -45.6% | 254,042 | -9.3% | 0.00% | -50.0% |
| Q4 2020 | $19,630,000 | +180.1% | 279,994 | +12.1% | 0.00% | +100.0% |
| Q3 2020 | $7,009,000 | -25.1% | 249,779 | -21.0% | 0.00% | 0.0% |
| Q2 2020 | $9,357,000 | +84.4% | 316,361 | +23.6% | 0.00% | 0.0% |
| Q1 2020 | $5,075,000 | -34.0% | 255,978 | -1.5% | 0.00% | 0.0% |
| Q4 2019 | $7,694,000 | +35.1% | 259,844 | +3.8% | 0.00% | 0.0% |
| Q3 2019 | $5,694,000 | +10.7% | 250,383 | +20.5% | 0.00% | +100.0% |
| Q2 2019 | $5,142,000 | -4.5% | 207,803 | -5.6% | 0.00% | -50.0% |
| Q1 2019 | $5,382,000 | +18.0% | 220,107 | +9.8% | 0.00% | +100.0% |
| Q4 2018 | $4,562,000 | -27.9% | 200,502 | +0.8% | 0.00% | -50.0% |
| Q3 2018 | $6,327,000 | -8.6% | 198,851 | +2.9% | 0.00% | 0.0% |
| Q2 2018 | $6,925,000 | +2.4% | 193,272 | -5.2% | 0.00% | 0.0% |
| Q1 2018 | $6,761,000 | +38.1% | 203,955 | +28.0% | 0.00% | +100.0% |
| Q4 2017 | $4,895,000 | +21.2% | 159,301 | -5.3% | 0.00% | 0.0% |
| Q3 2017 | $4,039,000 | +69.4% | 168,215 | +18.4% | 0.00% | 0.0% |
| Q2 2017 | $2,385,000 | +68.2% | 142,122 | +123.8% | 0.00% | – |
| Q1 2017 | $1,418,000 | +111.0% | 63,490 | +53.3% | 0.00% | – |
| Q4 2016 | $672,000 | +29.2% | 41,429 | +7.5% | 0.00% | – |
| Q3 2016 | $520,000 | -23.2% | 38,551 | +39.0% | 0.00% | – |
| Q2 2016 | $677,000 | +13.8% | 27,739 | +61.0% | 0.00% | – |
| Q1 2016 | $595,000 | – | 17,225 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NIA IMPACT ADVISORS, LLC | 54,615 | $4,897,000 | 2.55% |
| Capital Impact Advisors, LLC | 130,000 | $9,114,000 | 2.24% |
| ARK Investment Management | 10,125,564 | $709,903,000 | 1.89% |
| Nikko Asset Management Americas, Inc. | 4,388,143 | $307,653,000 | 1.75% |
| Spectrum Planning & Advisory Services Inc. | 17,522 | $1,228,000 | 1.32% |
| DDD Partners, LLC | 79,527 | $5,576,000 | 1.10% |
| Brevan Howard Capital Management LP | 76,420 | $5,358,000 | 1.08% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 538,721 | $37,770,000 | 0.75% |
| DC Investments Management, LLC | 3,627 | $254,000 | 0.63% |
| Haafor (Singapore) Pte. Ltd. | 4,761 | $334,000 | 0.62% |